An International Technology and Business Consultation Firm In Bio, Medical, and Healthcare Sciences
An international consultation firm focusing on biotechnology and medical/healthcare technology/products.
Supporting clients’ business deployment through a wide network of Japanese industry-government-academia sectors.
Supporting clients’ international business development in collaboration with STII’s partners in U.S, Europe, and Asia.
Providing wide range of consulting services as technology development, product development, business development, market development, clinical development, regulatory support, corporate alliance, and financing/fund-raise.
MISSION and COMPANY OVERVIEW
STI International, Inc. (STII) is a leading international consultation firm specializing in life sciences, biotechnology, medical science, and the healthcare field. STII effectively promotes the strategic business development goals of its client companies worldwide. STII focuses primarily on the biomedical area including biotechnology, life sciences, medical science, healthcare, and Medical Informatics. In addition, consultation services are also offered to food and foodstuff industries. By the combination of skilled consultants and excellent partners in the U.S., Europe, Asia, and Japan, STII provides highly efficient services to its clients.
STI International, Inc. (STII) offers consultation services to U.S. and European biomedical or life sciences companies seeking business opportunity in Japan and Asia. STII also assists Japanese companies in finding strategic partners in the U.S., Europe, and the Asia Pacific regions. STII also assists clients in accelerating business/product development efforts in Japan and the Far East.
STII promotes international business alliance such as US - Japan, ECU - Japan, and Asia – Japan. The major business areas that STII is involved in are Biotechnology, Medical Science, Healthcare, Medial Informatics, and Bio Informatics. STII can also support the clients’ import/export businesses and provide intellectual property management services.
STII also acts as a consultant for corporate executives and other key personnel at client firms assisting them in the decision-making process in business development and strategic partnering activities.
STII's staffs have strong backgrounds in business development, and medical and biotechnology, gained by academic knowledge or extensive work experience. Bilingual consultants understand differences between business culture and styles in the U.S., Europe, and Asian countries, and can act as the liaison between cultures for their clients.
STII maintains strong relationships with companies, regulatory authorities, academia, and hospitals in Japan. STII developed tight links to many companies around the world in the life sciences and the biomedical fields.
STII supports clients' business growth by providing wide range of consultation services.
Clinical Development and Regulatory Affairs
Venture Business Establishment
Financing and Fund Raising
Covered Fields in Consultation
STII provides a high-level consulting services to its clients covering following fields.
Biotechnologies and Biochemical Research
» Bio Research Technologies
Protein and Gene Research (Proteomics and Genomics)
Cell Separation and analysis
» Bio Research Products
Research Reagents, Instruments, and Devices
Microfluidics(Microarray, DNA Chip)
Medical Technology and Products
In Vitro Diagnostics (IVD)
Medical Software and Program Medical Devices
Regenerative Medicine (Cell Therapy and Gene Therapy)
Clinical Reference Laboratory Services
Tests for Preventive Medicine (Protein and Gene)
Target Diseases for Consultation
STII has an extensive experience on diagnostic and therapeutic products for the following diseases.
Endocrine Disorders, etc.
SOME EXAMPLES of PROJECTS DONE
STII had successfully performed a wide range of projects. (Technology and market development)
In Vitro Diagnostics (IVD) and Laboratory Tests
Breast cancer predictive MDx for selection of modality (OncotypeDx)
Women’s Health (Infertility) tests (NGS): Varinos’s intrauterine Flora assay, etc.
Non-invasive prenatal tests (MaterniT21)
Comprehensive analysis of cancer relating genes (NGS)
Oral cancer ELISA kit:GST-π
MDx for Atherosclerosis
Analyzers (Chemistry, Immunoassay) and POCT
Drug for acute alcoholism (small molecule)
Combination Drug for orthopedic knee surgery
Drug for HCC): Selective FGR4 covalent inhibitor
Stem cell adjuvant therapy for hepatocarcinoma
Drug for glaucoma (dual FP/EP3 prostaglandin agonist)
Cell therapy and Gene therapy
RFA for liver cancer (radiofrequency ablation)
Program medical device for diagnosis of major neurocognitive disorder
Drug coated stent
Bio Research Products
Research reagents for molecular biology
Microarray/Micro fluidics: many projects
DNA Chip and protein chip
FFlow Cytometer/Cell Sorter
Gene amplification reagent
Financing and VB Establishment
Collaboration with venture capitals (WVP, etc.)
Consulting for venture capitals
Advise and support to Bio VBs (drug discovery, IVD, etc.)
LIST of STRATEGIC RESEARCH PROJECTS PERFORMED
Examples of Strategic Research Projects performed thorough collaboration with STII’s U.S. partners.
Pharmaceuticals and Treatment
Liver Cancer Drug
Liver and Kidney Cancer Drug
Bladder and Kidney Cancer Drug
Inflammatory Bowel Diseases Drug
Bladder Cancer Drug
Ovarian Cancer Drug
Oral Mucosa Drug
Renal Cancer Drug
Plasmin Ischemic *Encephalopathy Drug
Prostate Cancer Radiopharmaceutical
Brain and Lung Cancer and Sarcoma Drug
Gynecology and Breast Cancer Drug
Stress Urinary Diseases Drug
MAb Drug on Ovarian Cancer
CRO Lead Removal Device
Intraosseous Infusion Device
Brain Aneurysm Embolization Coil Device
Dental Care Product
HT and HF
Urological BPH Device
Laser Technology Device
IVD and Laboratory Test
Allergy and autoimmune Diseases Tests
Anatomic pathology system
HCV HBV Diagnostics
LIS Laboratory Information System
MTB PCR test
POCT Molecular Screening System for Hospital Associated Infections
Laboratory Performance metrics
LDTs for infectious diseases, oncology or genetics
Molecular LDT tests using PCR for infectious diseases
Multiple Chemistry Assays per Dry Slide
Reagent automation module for analyzer
Tatsuzo Ishigami Ph.D., FAACC, President and CEO
STI International, Inc., President and CEO
Watervein Partners, Inc., Representative Director and Partner
On-Chip Biotechnologies Corporation, External Director
Tokiwa Bio, Inc., External Director
Varinos Corporation, External Director
Graduated from Nagoya University, Faculty of Science, Department of Chemistry
M.S. in Chemistry, Faculty of Science and Technology, Sophia University
Ph.D. (Doctor of Science degree) from Sophia University
Assistant Professor, Department of Chemistry, Aoyama Gakuin University
Director of Main Laboratory, Biochemicals Division, Bristol-Myers Japan K.K
Deputy Lab Director, Executive Director of Advanced Business Planning, etc. SRL, Inc.
President and Representative Director, Clontech Japan, K.K.
STI International, Inc., President and CEO (present post)
Watervein Partners, Inc., Executive Partner
On-Chip Biotechnologies Corporation, External Director (present post)
Varinos Corporation, External Director (present post)
Tokiwa Bio, Inc., External Director (present post)
Watervein Partners, Inc., Representative Director and Partner (present post)
Dr. Ishigami hosts following groups as owners on LinkedIn, an international business network (Numbers of Members are as of 2022/01/11)